Recruitment of natural killer cells in advanced stages of endogenously arising B-cell lymphoma: Implications for therapeutic cell transfer

Journal of Immunotherapy

Volumn 35, Issue 3, 2012, Pages 217-222

  Przewoznik, Margarethe ^a   Hömberg, Nadine ^a   Naujoks, Marcella ^a   Pötzl, Johann ^a   Münchmeier, Niklas ^b   Brenner, Christoph D ^a   Anz, David ^b   Bourquin, Carole ^b   Nelson, Peter J ^b   Röcken, Martin ^c   Mocikat, Ralph ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

c myc; chemoattraction; NK cell activation; Th1 response

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12;

ADOPTIVE TRANSFER; ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CANCER GROWTH; CANCER MODEL; CANCER STAGING; CANCER THERAPY; CELL TRANSFER; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; TUMOR CELL; TUMOR MICROENVIRONMENT;

ADOPTIVE TRANSFER; ANIMALS; CELL LINE; CHEMOKINE CXCL10; CHEMOKINE CXCL9; CHEMOTAXIS, LEUKOCYTE; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOMA, B-CELL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM STAGING; RECEPTORS, CXCR3;

EID: 84858769785     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/CJI.0b013e318247440a     Document Type: Article

References (30)

1. Lanier LL. NK cell recognition. Annu Rev Immunol. 2005; 23:225-274. (Pubitemid 40563170)
2. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol. 1999;17:875-904. (Pubitemid 29241142)
3. Mocikat R, Braumüller H, Gumy A, et al. Natural killer cells activated by MHC class Ilow targets prime dendritic cells to induce protective CD8 T cell responses. Immunity. 2003; 19:561-569. (Pubitemid 37311437)
4. Biron CA, Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol. 2001;13: 458-464. (Pubitemid 32728479)
5. Martín-Fontecha A, Thomsen LL, Brett S, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol. 2004;5:1260-1265. (Pubitemid 41057741)
6. Walzer T, Dalod M, Robbins SH, et al. Natural-killer cells and dendritic cells: "l'union fait la force". Blood. 2005; 106:2252-2258. (Pubitemid 41510793)
7. Macatonia SE, Hosken NA, Litton M, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol. 1995;154:5071-5079.
8. Arai S, Klingemann HG. Natural killer cells: can they be useful as adoptive immunotherapy for cancer? Expert Opin Biol Ther. 2005;5:163-172. (Pubitemid 40388846)
9. Miller JS, Soignier Y, Panoskaltsis-Mortari A, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005;105: 3051-3057.
10. Grégoire C, Chasson L, Luci C, et al. The trafficking of natural killer cells. Immunol Rev. 2007;220:169-182. (Pubitemid 350045566)
11. Hokeness KL, Kuziel WA, Biron CA, et al. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver. J Immunol. 2005;174:1549-1556.
12. Grégoire C, Cognet C, Chasson L, et al. Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation. Eur J Immunol. 2008;38:2076-2084.
13. Huang D, Shi FD, Jung S, et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 2006;20:896-905. (Pubitemid 44943947)
14. Yu YR, Fong AM, Combadiere C, et al. Defective antitumor responses in CX3CR1-deficient mice. Int J Cancer. 2007; 121:316-322. (Pubitemid 46917700)
15. Xin H, Kikuchi T, Andarini S, et al. Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells. Eur J Immunol. 2005;35:1371-1380. (Pubitemid 40691418)
16. Lavergne E, Combadiere B, Bonduelle O, et al. Fractalkine mediates natural killer-dependent antitumor responses in vivo. Cancer Res. 2003;63:7468-7474. (Pubitemid 37413490)
17. Liu C, Lou Y, Lizee G, et al. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell crosspriming and tumor regression in mice. J Clin Invest. 2008; 118:1165-1175. (Pubitemid 351364623)
18. Pan J, Burdick MD, Belperio JA, et al. CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis. J Immunol. 2006;176: 1456-1464. (Pubitemid 43134288)
19. Walser TC, Ma X, Kundu N, et al. Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model. J Immunother. 2007;30:490-498. (Pubitemid 46988082)
20. Fujihara A, Kurooka M, Miki T, et al. Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation. Cancer Immunol Immunother. 2008;57:73-84. (Pubitemid 350043650)
21. Saudemont A, Jouy N, Hetuin D, et al. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood. 2005;105:2428-2435. (Pubitemid 40387042)
22. Wendel M, Galani IE, Suri-Payer E, et al. Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands. Cancer Res. 2008;68:8437-8445.
23. Brenner CD, King S, Przewoznik M, et al. Requirements for control of B-cell lymphoma by NK cells. Eur J Immunol. 2010;40:494-504.
24. Kovalchuk AL, Qi CF, Torrey TA, et al. Burkitt lymphoma in the mouse. J Exp Med. 2000;192:1183-1190.
25. Sauty A, Colvin RA, Wagner L, et al. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11). J Immunol. 2001;167:7084-7093. (Pubitemid 33144205)
26. Adam C, King S, Allgeier T, et al. DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood. 2005;106:338-344. (Pubitemid 40967210)
27. Costello RT, Sivori S, Marcenaro E, et al. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood. 2002;99:3661-3667. (Pubitemid 34534536)
28. Ishigami S, Natsugoe S, Tokuda K, et al. Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer. 2000;88:577-583. (Pubitemid 30056932)
29. Venetz D, Ponzoni M, Schiraldi M, et al. Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells. Int J Cancer. 2010;127:2300-2312.
30. Drennan MB, Franki AS, Dewint P, et al. Cutting edge: the chemokine receptor CXCR3 retains invariant NK T cells in the thymus. J Immunol. 2009;183:2213-2216.